Huanlin Xianan Pian (环磷酰胺片)环磷酰胺片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 公主岭市红光制药厂Chinese legal name: 公主岭市红光制药厂
主要成分Active Ingredients
- 环磷酰胺DHuanlin Xianan
药物知识说明
环磷酰胺D是一种在国家药监局注册认定的药品。该药品含有环磷酰胺d-3ac17600等成分。
该药品关联的活性成分包括：环磷酰胺d。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：公主岭市红光制药厂Chinese legal name: 公主岭市红光制药厂。
您可以探索含有相同成分的其他药品：环磷酰胺d-3ac17600成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 环磷酰胺片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Manufacturers recorded for this product: 公主岭市红光制药厂Chinese legal name: 公主岭市红光制药厂.
Explore other medicines containing the same ingredient: 环磷酰胺d productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 环磷酰胺片Recorded Chinese name: 环磷酰胺片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 50mg50 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 公主岭市红光制药厂Chinese legal name: 公主岭市红光制药厂
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H22022406
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H22022406
Manufacturer
Chinese legal name: 公主岭市红光制药厂 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H22022406
生产企业
公主岭市红光制药厂(国产)
适应症
本品为目前广泛应用的抗癌药物,对恶性淋巴瘤、急性或慢性淋巴细胞白血病、多发性骨髓瘤有较好的疗效,对乳腺癌、睾丸肿瘤、卵巢癌、肺癌、头颈部鳞癌、鼻咽癌、神经母细胞瘤、横纹肌肉瘤及骨肉瘤均有一定的疗效。
用法用量
口服给药:|1.成人常用量:每日2～4mg/kg,连用10～14天,休息1～2周重复.|2.儿童常用量:每日2～6mg/kg,连用10～14天,休息1～2周重复.
不良反应
1.骨髓抑制:白细胞减少最常见,最低值在用药后1～2周,多在2～3周后恢复。对血小板影响较小。可影响肝功。|2.胃肠道反应:包括食欲减退、恶心及呕吐,一般停药1～3天即可消失。|3.泌尿道反应:可致出血性膀胱炎,表现为膀胱刺激症状、少尿、血尿及蛋白尿,系其代谢产物丙烯醛刺激膀胱所致,但环磷酰胺常规剂量应用时,其发生率较低。|4.其他反应尚包括脱发、口腔炎、中毒性肝炎、皮肤色素沉着、月经紊乱、无精子或精子减少及肺纤维化等。
禁忌
1.抗癌药物,必须在有经验的专科医生指导下用药。|2.凡有骨髓抑制、感染、肝肾功能损害者禁用或慎用。|3.对本品过敏者禁用。|4.妊娠及哺乳期妇女禁用。
注意事项
本品的代谢产物对尿路有刺激性,应用时应鼓励患者多饮水,大剂量应用时应水化、利尿,同时给予尿路保护剂美司钠。近年研究显示,提高药物剂量强度,能明显增加疗效,当大剂量用药时,除应密切观察骨髓功能外,尤其要注意非血液学毒性如心肌炎、中毒性肝炎及肺纤维化等。当肝肾功能损害、骨髓转移或既往曾接受多程化放疗时,环磷酰胺的剂量应减少至治疗量的1/2～1/3。由于本品需在肝内活化,因此腔内给药无直接作用。
贮藏
遮光，密封，在30℃以下保存
规格
50mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.